RESTON, Va., Sept. 29, 2016 /PRNewswire/ -- Leidos Holdings, Inc. (Leidos) (NYSE: LDOS), a national security, health and infrastructure solutions company, has scheduled a conference call for Thursday, November 3, 2016, at 8:00 AM ET to announce its third quarter 2016 financial results for the period ending Friday, September 30, 2016. The company plans to issue its quarterly earnings press release before the conference call on November 3, 2016.
Date: November 3, 2016
Time: 8:00 AM (ET)
To Listen via the Internet:
We are pleased to offer a live and replay audio broadcast of the conference call with corresponding slides at http://ir.leidos.com.
To Listen via Telephone:
877-869-3847 (toll-free U.S.)
+1-201-689-8261 (for International Callers)
A telephone playback of the third quarter 2016 earnings conference call is scheduled to be available beginning at 11:00 AM (ET) on November 3, 2016, through 11:59 PM (ET) on November 10, 2016. The replay will be accessible by calling 877-660-6853 (International callers: 201-612-7415), and entering conference ID 13646428.
An archived version of the webcast will be available on the Leidos Investor Relations website at http://ir.leidos.com.
Leidos is a global science and technology solutions leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported pro forma annual revenues of approximately $10 billion for the fiscal year ended Jan. 1, 2016 after giving effect to the recently completed combination of Leidos with Lockheed Martin's Information Systems & Global Solutions business (IS&GS). For more information, visit www.Leidos.com.
Kelly P. Hernandez
Last updated on: 30/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.